InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
4
T+90 hit rate
100%
T+90 mean return
+39.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Glenn Gregory M, Strategic Research & Development Advisor; former President, Research and Development at Novavax. Director active across 1 company, notably NOVAVAX INC. In total, 27 disclosures have been recorded. Breakdown: 2 buys · 4 sells. Total volume traded: €66k. History available since 17 May 2021. The latest transaction was filed on 6 March 2023 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Glenn Gregory M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations27 total
3,000 shares@ US$7.48450.8% of flowCommon StockSEC:0001209191-23-018545:0
Canonical exit: 4 Jun 2023 (T+90)
3,100 sharesCommon StockSEC:0001209191-22-061704:0
3,100 sharesCommon StockSEC:0001209191-21-070012:0
8,250 shares@ US$19.0810.7% of flowCommon StockSEC:0001209191-21-068836:0
8,250 shares@ US$19.0810.7% of flowCommon StockSEC:0001209191-21-067558:0
2,083 shares@ US$5.950.8% of flowCommon StockSEC:0001209191-21-067151:0
8,250 shares@ US$19.0810.7% of flowCommon StockSEC:0001209191-21-066826:0
521 shares@ US$27.601.0% of flowCommon StockSEC:0001209191-21-065181:0
8,250 shares@ US$19.0810.4% of flowCommon StockSEC:0001209191-21-064260:0
8,250 shares@ US$19.0810.4% of flowCommon StockSEC:0001209191-21-062976:0
39 shares@ US$145.40770.4% of flowCommon StockSEC:0001209191-21-062506:0
2,084 shares@ US$5.950.8% of flowCommon StockSEC:0001209191-21-061919:0
8,250 shares@ US$19.0810.4% of flowCommon StockSEC:0001209191-21-061279:0
521 shares@ US$27.600.9% of flowCommon StockSEC:0001209191-21-060946:0
8,250 shares@ US$19.0810.4% of flowCommon StockSEC:0001209191-21-060488:0
8,250 shares@ US$19.0810.4% of flowCommon StockSEC:0001209191-21-059956:0
51 shares@ US$202.83730.7% of flowCommon StockSEC:0001209191-21-058570:0
2,083 shares@ US$5.950.8% of flowCommon StockSEC:0001209191-21-058076:0
521 shares@ US$27.600.9% of flowCommon StockSEC:0001209191-21-056673:0
53 shares@ US$234.63940.8% of flowCommon StockSEC:0001209191-21-054286:0
4,167 shares@ US$5.951.6% of flowCommon StockSEC:0001209191-21-053905:0
544 shares@ US$27.601.0% of flowCommon StockSEC:0001209191-21-052280:0
119 shares@ US$200.60711.5% of flowCommon StockSEC:0001209191-21-047809:0
550 shares@ US$27.001.0% of flowCommon StockSEC:0001209191-21-047263:0
623 shares@ US$27.001.1% of flowCommon StockSEC:0001209191-21-041642:0
25 of 27 declarations
About Glenn Gregory M
Glenn Gregory M is a Strategic Research & Development Advisor and former President, Research and Development at Novavax, and the record attributes 27 filings to him in total. In the sampled recent filings, from 2016-02-01 to 2023-03-14, the aggregated amounts are EUR 21130 for buys and EUR 44579 for sells, with Levée d'options as the most common transaction nature.
